These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3931693)

  • 1. Structure-dependent induction of bilirubin glucuronidation and lauric acid 12-hydroxylation by arylcarboxylic acids chemically related to clofibrate.
    Fournel S; Magdalou J; Thomassin J; Villoutreix J; Siest G; Caldwell J; André JC
    Biochim Biophys Acta; 1985 Oct; 842(2-3):202-13. PubMed ID: 3931693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereospecific induction of rat liver bilirubin UDPglucuronosyltransferase and lauric acid 12-hydroxylation by the isomers of 2-phenylpropionic acid.
    Fournel S; Caldwell J; Magdalou J; Siest G
    Biochim Biophys Acta; 1986 Jul; 882(3):469-72. PubMed ID: 3089296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid.
    Orton TC; Parker GL
    Drug Metab Dispos; 1982; 10(2):110-5. PubMed ID: 6124394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of clofibric acid and bilirubin glucuronidation in human liver microsomes.
    Dragacci S; Hamar-Hansen C; Fournel-Gigleux S; Lafaurie C; Magdalou J; Siest G
    Biochem Pharmacol; 1987 Nov; 36(22):3923-7. PubMed ID: 3120730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel rat hepatic clofibrate-inducible cytochrome P450 that is not a lauric acid hydroxylase.
    Swinney DC; Webb AS; Freedman R
    Biochem Pharmacol; 1991 Nov; 42(12):2341-9. PubMed ID: 1662512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential action of thyroid hormones and chemically related compounds on the activity of UDP-glucuronosyltransferases and cytochrome P-450 isozymes in rat liver.
    Goudonnet H; Magdalou J; Mounie J; Naoumi A; Viriot ML; Escousse A; Siest G; Truchot R
    Biochim Biophys Acta; 1990 Jul; 1035(1):12-9. PubMed ID: 2116906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro hydroxylation and epoxidation of some isomeric lauric acid analogs by rat liver microsomes. Identification of metabolites and effects of clofibrate or phenobarbital pretreatment.
    Boucher JL; Delaforge M; Salaün JP; Pinot F; Durst F; Pflieger P; Mioskowski C
    Drug Metab Dispos; 1996 Apr; 24(4):462-8. PubMed ID: 8801062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-suppression by nicardipine, a calcium antagonist, of induction of microsomal lauric acid hydroxylation with peroxisome proliferation in clofibrate-treated rat liver.
    Watanabe T; Itoga H; Okawa S; Tamura H; Suga T
    Chem Pharm Bull (Tokyo); 1991 May; 39(5):1320-2. PubMed ID: 1914008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid).
    Gibson GG; Orton TC; Tamburini PP
    Biochem J; 1982 Apr; 203(1):161-8. PubMed ID: 7103935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of lauric acid hydroxylation and maintenance of cytochrome P-450 content by clofibrate in primary cultures of rat hepatocytes.
    Lake BG; Gray TJ; Stubberfield CR; Beamand JA; Gangolli SD
    Life Sci; 1983 Jul; 33(3):249-54. PubMed ID: 6865658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical study on the contribution of hypolipidaemic-induced cytochrome P-452 to the metabolism of lauric acid and arachidonic acid.
    Bains SK; Gardiner SM; Mannweiler K; Gillett D; Gibson GG
    Biochem Pharmacol; 1985 Sep; 34(18):3221-9. PubMed ID: 3929789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific induction and inactivation of cytochrome P450 catalysing lauric acid hydroxylation in the sea bass, Dicentrarchus labrax.
    Sabourault C; de Sousa G; Amichot M; Cuany A; Rahmani R; Salaün JP; Bergé JB; Girard JP; Lafaurie M
    Comp Biochem Physiol B Biochem Mol Biol; 1999 Feb; 122(2):253-60. PubMed ID: 10327614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative induction of drug-metabolizing enzymes by hypolipidaemic compounds.
    Boiteux-Antoine AF; Magdalou J; Fournel-Gigleux S; Siest G
    Gen Pharmacol; 1989; 20(4):407-12. PubMed ID: 2502468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of bilirubin UDPglucuronosyltransferase activity by triphenylacetic acid and related compounds.
    Fournel S; Grégoire B; Magdalou J; Carre MC; Lafaurie C; Siest G; Caubère P
    Biochim Biophys Acta; 1986 Sep; 883(2):190-6. PubMed ID: 3091075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical characterization of lauric acid omega-hydroxylation by a CYP4A1/NADPH-cytochrome P450 reductase fusion protein.
    Chaurasia CS; Alterman MA; Lu P; Hanzlik RP
    Arch Biochem Biophys; 1995 Feb; 317(1):161-9. PubMed ID: 7872779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hypolipidemic compounds on lauric acid hydroxylation and phase II enzymes.
    Thomas H; Schladt L; Knehr M; Post K; Oesch F; Boiteux-Antoine AF; Fournel-Gigleux S; Magdalou J; Siest G
    Biochem Pharmacol; 1989 Jun; 38(12):1963-9. PubMed ID: 2500933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heteroatom substitution shifts regioselectivity of lauric acid metabolism from omega-hydroxylation to (omega-1)-oxidation.
    Alterman MA; Chaurasia CS; Lu P; Hanzlik RP
    Biochem Biophys Res Commun; 1995 Sep; 214(3):1089-94. PubMed ID: 7575514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in the hepatic glucuronidation and clearance of bilirubin in clofibrate-treated rats.
    Foliot A; Drocourt JL; Etienne JP; Housset E; Fiessinger JN; Christoforov B
    Biochem Pharmacol; 1977 Mar; 26(6):547-9. PubMed ID: 403920
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential induction profile of drug-metabolizing enzymes after treatment with hypolipidaemic agents.
    Fournel S; Magdalou J; Pinon P; Siest G
    Xenobiotica; 1987 Apr; 17(4):445-57. PubMed ID: 2885979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel inhibitors and substrates of bilirubin: UDP-glucuronosyltransferase. Arylalkylcarboxylic acids.
    Fournel-Gigleux S; Shepherd SR; Carre MC; Burchell B; Siest G; Caubere P
    Eur J Biochem; 1989 Aug; 183(3):653-9. PubMed ID: 2776759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.